KCT0008111
Completed
未知
ong-term clinical outcome of chronic hepatitis B naive patients treated with entecavir and tenofovir in Korea
Hallym University Medical Center-Dongtan0 sites2,000 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Certain infectious and parasitic diseases
- Sponsor
- Hallym University Medical Center-Dongtan
- Enrollment
- 2000
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who were prescribed entecavir as an initial treatment for chronic hepatitis B between January 2011 and January 2014
- •Patients who were prescribed tenofovir as an initial treatment for chronic hepatitis B between December 2012 and December 2015
Exclusion Criteria
- •Patients who could not be followed up within 1 year after administration of entecavir or tenofovir
- •Patients diagnosed with liver cancer before and within 1 year after administration of entecavir or tenofovir
- •Patients diagnosed with other types of malignancies during the 5 years prior to administration of entecavir or tenofovir
- •Patients co\-infected with HCV or HIV
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)Chronic hepatitis BJPRN-UMIN000031832Stanford University Medical Center270
Recruiting
Not Applicable
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate PhaseChronic Hepatitis bNCT05661786The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School4,500
Active, not recruiting
Not Applicable
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW StudyEUCTR2006-000421-62-GRBristol-Myers Squibb International Corporation462
Active, not recruiting
Not Applicable
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir Plus Tenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 6.1Level: PTClassification code 10019731EUCTR2006-000421-62-ITBristol-Myers Squibb International Corporation462
Active, not recruiting
Phase 1
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 8.1Level: LLTClassification code 10019743Term: Hepatitis B virus (HBV)EUCTR2006-000421-62-FRBristol-Myers Squibb International Corporation462